![Dorman Followwill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dorman Followwill
Directeur/Membre du Conseil chez
SCILEX HOLDING COMPANY
Fortune : 507 $ au 30/06/2026
Profil
Dorman Followwill is currently an Independent Director at Semnur Pharmaceuticals, Inc. since 2025, an Independent Director at Scilex Holding Co. since 2022, and a Senior Partner-Transformational Health at Frost & Sullivan, Inc. since 2016.
Former positions include Independent Director at Scilex, Inc. in 2022 and Independent Director at Sorrento Therapeutics, Inc. from 2017 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/04/2026 | 65 ( 0 % ) | 507 $ | 30/06/2026 |
Postes actifs de Dorman Followwill
| Sociétés | Poste | Début |
|---|---|---|
| SCILEX HOLDING COMPANY | Directeur/Membre du Conseil | 10/11/2022 |
Frost & Sullivan, Inc.
 Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | 01/01/2016 |
Anciens postes connus de Dorman Followwill
| Sociétés | Poste | Fin |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Directeur/Membre du Conseil | 01/11/2022 |
| SORRENTO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Dorman Followwill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frost & Sullivan, Inc.
Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
